Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(E)-3,4-dihydroxy-N'-[(2-methoxynaphthalen-1-yl)methylene]benzohydrazide is an experimental small molecule compound belonging to the class of hydrazides and naphthalene derivatives. It has not been approved for any medical use and there are no known clinical trials or indications associated with it. The compound features a benzohydrazide core substituted with a methoxynaphthalene group and two hydroxyl groups on the benzene ring. Its mechanism of action is not established in public databases or literature[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (E)-3,4-dihydroxy-N'-[(2-methoxynaphthalen-1-yl)methylene]benzohydrazide.